Finance

Beta
Lists
1SRT:BIT
Sartorius AG
€176.80
-9.43%
(-18.40) 1D
Apr 15, 11:28:58 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1SRT...
Mkt. cap
16.15B
Avg. vol.
0.00
Volume
0.00
Dividend
0.41%
Quarterly dividend
€0.18
Ex-dividend date
Mar 27, 2026
P/E ratio
75.03
52-wk high
€209.50
52-wk low
€147.80
EPS
€2.36
No. of employees
14K
Mkt. cap
16.15B
Avg. vol.
0.00
Volume
0.00
Dividend
0.41%
Quarterly dividend
€0.18
Ex-dividend date
Mar 27, 2026
P/E ratio
75.03
52-wk high
€209.50
52-wk low
€147.80
EPS
€2.36
No. of employees
14K
News stories
From sources across the web
Profile
Sartorius AG is an international supplier of pharmaceutical and laboratory equipment. Founded in 1870, the company is headquartered in Göttingen, Germany. It provides tools and services for the biopharmaceutical industry. The company operates through two divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
About Sartorius AG
CEOMichael Grosse
Employees14.2K
Founded1870
Headquarters-
SectorHealth care
Websitesartorius.com
Last report
Apr 23, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
€1.20 / €1.27
-5.57%miss
Revenue / Est. (EUR)
899.10M / 901.65M
-0.28%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
884.30M
843.20M
927.60M
899.10M
Cost of goods sold
468.10M
450.00M
531.20M
484.60M
Cost of revenue
468.10M
450.00M
531.20M
484.60M
Research and development expenses
41.60M
40.40M
41.50M
49.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
225.20M
218.70M
223.10M
221.30M
Operating expense
284.30M
263.60M
227.70M
260.70M
Total operating expenses
752.40M
713.60M
758.90M
745.30M
Operating income
131.90M
129.60M
168.70M
153.80M
Other non operating income
-13.20M
100.00K
-26.20M
100.00K
EBT including unusual items
70.90M
85.00M
81.60M
111.00M
EBT excluding unusual items
70.90M
85.00M
109.70M
111.00M
Income tax expense
19.10M
22.90M
37.60M
30.00M
Effective tax rate
26.94%
26.94%
46.08%
27.03%
Other operating expenses
17.50M
4.50M
-36.90M
-9.70M
Net income
32.50M
43.80M
30.20M
56.20M
Net profit margin
3.68%
5.19%
3.26%
6.25%
Earnings per share
1.22
1.08
1.26
1.20
Interest and investment income
-
4.80M
17.40M
20.10M
Interest expense
-47.80M
-49.50M
-31.80M
-63.00M
Net interest expenses
-47.80M
-44.70M
-14.40M
-42.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
234.40M
233.20M
177.60M
260.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer